Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 121
Filter
1.
Journal of Private International Law ; 18(1):113-145, 2022.
Article in English | Scopus | ID: covidwho-1890681

ABSTRACT

Substituted service is an important and frequently used method to bring judicial documents to a defendant’s attention when service of process in the manner otherwise required by the civil procedure rule is impracticable. Between substituted service and the Hague Service Convention 1965 exists a tension: as the scope of substituted service expands, the application of the Convention shrinks. The tension predated the pandemic but has become increasingly acute as Australian courts have frequently been called upon to address when substituted service may be ordered to replace service under the Convention. Addressing this tension is significant but complex as it involves Australia's international obligation to follow the Convention, a plaintiff's legitimate expectation to quickly effect service of process, and a defendant's fundamental right to due process. This paper is a digest of Australian private international law on substituted service. It provides timely proposals both at the domestic and international dimensions to address this tension. © 2022 Informa UK Limited, trading as Taylor & Francis Group.

2.
Acta Medica Mediterranea ; 38(3):1935-1939, 2022.
Article in English | EMBASE | ID: covidwho-1887391

ABSTRACT

Introduction: After the outbreak of the Corona Virus Disease 2019 (COVID-19), there have been reports of impaired cardiac function in patients infected with this coronavirus. The tests are mostly based on myocardial injury markers and routine cardiac ultrasound examinations, which are mostly seen in critically ill patients. In this study, two-dimensional speckle tracking imaging (2DSTI) combined with Tei index and serum N-terminal pro-brain natriuretic peptide (NT-proBNP) were used to more sensitively diagnose cardiac function impairment in COVID-19 patients. Materials and methods: For some COVID-19 patients in our hospital, there were 68 cases of mild disease (including mild and common types) and 11 cases of severe disease (4 cases of severe death), and 10 healthy volunteers were included as the control group. On the basis of conventional echocardiography in all subjects, the left ventricular end-diastolic volume (LV-EDV), left ventricular end-systolic volume (LV-ESV), and left ventricular ejection fraction (LV-EF) were obtained by Simpson method, the left ventricular Tei index by tissue Doppler, and the left ventricular global peak longitudinal strain (GLPS), left ventricular global peak radial strain (GRPS), and left ventricular global peak circumferential strain (GCPS) by 2DSTI offline analysis. The COVID-19 patients were subjected to quantitative detection of serum NT-proBNP for statistical analysis. Results: Left ventricular GLPS, left ventricular GRPS, and left ventricular GCPS in COVID-19 patients were significantly lower than those in the control group (P<0.05): The left ventricular GLPS was more significant (P<0.01), and the severe group (including the death group) < the mild group < the control group. The left ventricular Tei index: The severe group (including the death group) of COVID-19 was significantly higher than the mild group and the control group (P<0.05), and there was no statistical significance between the mild group and the control group. NT-proBNP: The severe group of COVID-19 was significantly higher than the mild group (P<0.05). Although the LV-EF in the COVID-19 patients was significantly lower than that in the control group (P<0.05), except for 2 sever cases less than 50%, the rest were all ≥50%;although there was a significant difference in LV-ESV among multiple groups (P<0.05), but there was no significant difference for the pairwise comparison, and there was no significant difference in LV-EDV. Conclusion: 2DSTI can more sensitively detect latent cardiac function impairment in COVID-19 patients, and the left ventricular GLPS is the most sensitive. Tei index is an effective indicator to reflect the degree of cardiac function impairment. NT-proBNP has significant significance in predicting the severity of cardiac dysfunction. The combined application of the three can significantly increase the predictive performance of cardiac function impairment, provide a diagnostic basis for cardiac function impairment with preserved ejection fraction, and predict the degree of impairment. Our study demonstrated that the cardiac function of COVID-19 patients is impaired to varying degrees.

3.
Clinical Laboratory ; : 11, 2022.
Article in English | Web of Science | ID: covidwho-1887317

ABSTRACT

Background: The outbreak of SARS-CoV-2 lead to a worldwide pandemic which poses substantial challenges to public health. Methods: We enrolled 102 consecutive recovered patients with laboratory-confirmed SARS-CoV-2 infection. Epidemiological and demographic characteristics, temporal dynamic profiles of laboratory tests and findings on chest CT radiography, and clinical outcomes were collected and analyzed. Results: Independent risk factors for prolonged fever, viral RNA shedding or radiologic recovery included age of more than 44 years, female gender, having symptoms of cough and fever, a delay from the symptom onset to hospitalization of more than 3 days, a lower CD4 count of less than 500/mu L on admission, and severe or critical illness in hospitalization. The estimated median time from symptom onset was 6.4 (5.5 -7.4) days to peak viral load, 9.1 (7.9 -10.4) days to afebrile, 8 (6.7 -9.4) days to worst radiologic finding, 12.7 (11.2 -14.3) days to viral RNA negativity, and 26.7 (23.8 -29.9) days to radiologic resolution. This study included the entire cross-section of patients seen in our clinical practice and reflected the real-world situation. Conclusions: These findings provide the rationale for strategies of active symptom monitoring, timing of quarantine and antiviral interventions, and duration of radiologic follow-up in patients with COVID-19.

4.
BMC Anesthesiol ; 22(1): 179, 2022 06 09.
Article in English | MEDLINE | ID: covidwho-1883517

ABSTRACT

BACKGROUND: Neuraxial blocks is the recommended mode of analgesia and anesthesia in parturients with Coronavirus 19 (COVID-19). There is limited data on the hemodynamic responses to neuraxial blocks in COVID-19 patients. We aim to compare the hemodynamic responses to neuraxial blocks in COVID-19 positive and propensity-matched COVID-19 negative parturients. METHODS: We conducted retrospective, cross-sectional case-control study of hemodynamic changes associated with neuraxial blocks in COVID-19 positive parturients in a Tertiary care academic medical center. Fifty-one COVID-19 positive women confirmed by nasopharyngeal reverse transcription-polymerase chain reaction (RT-PCR), were compared with propensity-matched COVID negative controls (n = 51). Hemodynamic changes after neuraxial block were recorded by electronic medical recording system and analyzed using paired and unpaired T- test and Wilcoxon-Mann-Whitney Rank Sum tests. The primary outcome was ≥ 20% change in MAP and HR after neuraxial block placement. RESULTS: In the epidural group, 7% COVID-19 positive parturients had > 20% decrease in mean arterial pressure (MAP) from baseline compared to 15% COVID-19 negative parturients (P = 0.66). In the spinal group, 83% of COVID-19 positive parturients had a decrease in MAP more than 20% from baseline compared to 71% in control (P = 0.49). MAP drop of more than 40% occurred in 29% COVID positive parturients in the spinal group versus 17% in COVID-19 negative parturients (P = 0.5465). In COVID-19 positive spinal group, 54% required vasopressors whereas 38% in COVID-19 negative spinal group required vasopressors (P = 0.387). We found a significant correlation between body mass index (BMI) > 30 and hypotension in COVID ( +) parturient with odds ratio (8.63; 95% CI-1.93 - 37.21) (P = 0.007). CONCLUSION: Incidence and severity of hypotension after neuraxial blocks were similar between COVID-19 positive and COVID-19 negative parturients. BMI > 30 was a significant risk factor for hypotension as described in preexisting literature, this correlation was seen in COVID-19 positive parturients. The likely reason for parturients with BMI > 30 in COVID negative patients not showing similar correlation, is that the sample size was small.


Subject(s)
Anesthesia, Obstetrical , Anesthesia, Spinal , COVID-19 , Hypotension , Case-Control Studies , Cross-Sectional Studies , Female , Hemodynamics , Humans , Hypotension/epidemiology , Pregnancy , Pregnant Women , Retrospective Studies
5.
Science of Advanced Materials ; 14(2):408-413, 2022.
Article in English | English Web of Science | ID: covidwho-1883369

ABSTRACT

The management of breast cancer patients in the current COVID-19 outbreak is challenging. Myelosuppres-sion associated with cancer treatment may increase the risk of infection in both hospitals and at home. We implemented the following strategy to reduce myelosuppression of adjuvant chemotherapy during the COVID-19 pandemic: (1) changing the original regimen of AC x 4-* wT x 12 to wT x 12-* AC x 4. (2) substitution of standard paclitaxel with nanoparticle albumin-bound (nab)-paclitaxel (nab-paclitaxel). For 43 patients who com-IP: 14.98.160.66 On: Fri, 13 May 2022 09:27:55 pleted nab-paclitaxel treatment, the compliance rate was 100%, without interruption or delay of nab-paclitaxel Copyright: American Scientific Publishers Delivered by Ingenta treatment. Dose reduction was necessary in 2 patients (4.6%) due to peripheral neuropathy. Thus, 98.6% of the planned doses were administered. As expected, the adjusted adjuvant regimen was safe and well toler-ated. Therefore wT x 12-* AC x 4 treatment procedure may be considered for breast cancer patients during COVID-19 pandemic.

6.
Zhonghua Yu Fang Yi Xue Za Zhi ; 56(4): 474-478, 2022 Apr 06.
Article in Chinese | MEDLINE | ID: covidwho-1834947

ABSTRACT

Objective: To analyze the course of disease and epidemiological parameters of COVID-19 and provide evidence for making prevention and control strategies. Methods: To display the distribution of course of disease of the infectors who had close contacts with COVID-19 cases from January 1 to March 15, 2020 in Guangdong Provincial, the models of Lognormal, Weibull and gamma distribution were applied. A descriptive analysis was conducted on the basic characteristics and epidemiological parameters of course of disease. Results: In total, 515 of 11 580 close contacts were infected, with an attack rate about 4.4%, including 449 confirmed cases and 66 asymptomatic cases. Lognormal distribution was fitting best for latent period, incubation period, pre-symptomatic infection period of confirmed cases and infection period of asymptomatic cases; Gamma distribution was fitting best for infectious period and clinical symptom period of confirmed cases; Weibull distribution was fitting best for latent period of asymptomatic cases. The latent period, incubation period, pre-symptomatic infection period, infectious period and clinical symptoms period of confirmed cases were 4.50 (95%CI:3.86-5.13) days, 5.12 (95%CI:4.63-5.62) days, 0.87 (95%CI:0.67-1.07) days, 11.89 (95%CI:9.81-13.98) days and 22.00 (95%CI:21.24-22.77) days, respectively. The latent period and infectious period of asymptomatic cases were 8.88 (95%CI:6.89-10.86) days and 6.18 (95%CI:1.89-10.47) days, respectively. Conclusion: The estimated course of COVID-19 and related epidemiological parameters are similar to the existing data.


Subject(s)
COVID-19 , Contact Tracing , Cohort Studies , Humans , Incidence , Prospective Studies
7.
Chinese Journal of Evidence-Based Medicine ; 22(4):438-443, 2022.
Article in Chinese | EMBASE | ID: covidwho-1818644

ABSTRACT

Objective To systematically review the impact of ACEI/ARB (angiotensin converting enzyme inhibitor/angiotensin receptor antagonist) treatment on the clinical outcomes of Chinese patients with COVID-19 infections. Methods PubMed, EMbase, Web of Science, The Cochrane Library, CNKI, WanFang Data, and VIP databases were electronically searched to collect cohort studies on the impact of the treatment with ACEI/ARB on the clinical outcomes of Chinese patients with COVID-19 infections from January 2020 to January 2022. Two reviewers independently screened literature, extracted data, and assessed the risk of bias of the included studies. Then, meta-analysis was performed using RevMan 5.3 software. Results A total of 17 cohort studies involving 4 912 subjects were included. The results of meta-analysis showed that patients who were prescribed ACEI/ARB had shorter hospital stays (SMD=-0.28, 95%CI -0.46 to -0.11, P=0.002) and a lower mortality rate (OR=0.47, 95%CI 0.36 to 0.62, P<0.000 01) than patients who did not take ACEI/ARB. Conclusion Current evidence shows that the use of ACEI/ARB drugs can improve the clinical prognosis of Chinese patients with COVID-19 infections. Due to the limited quality and quantity of the included studies, more high-quality studies are needed to verify the above conclusion.

8.
Acupuncture & Electro-Therapeutics Research ; 47(2):195-201, 2022.
Article in English | Web of Science | ID: covidwho-1810380

ABSTRACT

Objective : Summarize the experience of transporting patients in the pre-hospital emergency center of our hospital from January 20, 2020 to May 2020 during the outbreak of novel coronavirus pneumonia in Zhuzhou City, and formulate a series of transport strategics. Methods: During the novel coronavirus pneumonia epidemic, review the relevant experience of the medical staff and drivers in the pre-hospital emergency center of Zhuzhou Central Hospital to improve the procedures for the transfer of patients during the epidemic. Results: As of the time when patients with novel coronavirus pneumonia in our city are cleared, none of the medical staff in the pre-hospital emergency center of Zhuzhou Central Hospital has been infected, and the city's patients in need of pre-hospital emergency treatment have been treated in an orderly manner. In conjunction with our hospital's epidemic prevention and control expert team, combined with the actual situation in the region, we jointly formulated a series of transfer procedures for Zhuzhou Central Hospital to comply with the region during the epidemic. Conclusion: During the novel coronavirus pneumonia epidemic, all patients received by the pre-hospital emergency center of our hospital were transferred in a timely and safe manner, and a series of transfer procedures were developed.

9.
Journal of Third Military Medical University ; 43(20):2241-2249, 2021.
Article in Chinese | Scopus | ID: covidwho-1789737

ABSTRACT

Objective To describe the clinical characteristics of liver and kidney injuries and investigate its effect on the severity and mortality in the COVID-19 patients.Methods A total of 3 548 patients diagnosed with COVID-19 hut without liver and kidney diseases admitted in the Huoshenshan Hospital, Jinyintan Hospital and Taikang Tongji Hospital from February 4, 2020 to April 16, 2020 were recruited in this study.Their clinical data were extracted from medical database, including general information, clinical features, laboratory results and outcomes such as death were collected and analyzed.SPSS statistics 23.0 was used to perform the statistical description and analysis.Results Among the 3 548 patients with COYID-19, 875 (24.7%) cases were severe illness and above and 91 (2.6%) died during hospitalization.The proportions of the patients with higher alanine amiotransferase ( ALT) , aspartate aminotransferase ( AST) and creatinine (Cr) were 14.6% (513/3 548) , 3.4% ( 1 19/3 548) and 2.8% ( 101/3 548), respectively.Compared with the patients with normal ALT, AST and Cr, the patients with elevated ALT did not have a significantly increased risk of severe illness or death ( /-∗>().05) , and the risk of severe illness and death was significantly increased in those with elevated AST and Cr ( P<0.05).The risk of severe disease was 2.32 times (95%CI: 1.73-3.10) and 1 1.40 times ( 95% CI: 2.36-54.98 ) for those with single or both liver and kidney injuries, and the risk of death was 5.21 times (95% CI: 3.10-8.75 ) and 13.53 times (95% CI: 2.76-66.32) for those with normal liver and kidney function, respectively.Logistic regression analysis indicated that after independent factors related to severe illness and death screened out as correction factors, the risk of severe illness and death was 1.612 times (95% CI: 1.17-2.22) and 2.907 times (95% CI: 1.61-5.24) of patients with liver or kidney injuries when compared with those with normal function, respectively.Conclusion The COYID-19 patients with liver and renal injuries have a significantly increased tendency to become severity and mortality, and should undergo early intervention. © 2021 Editorial Office of Journal of Third Military Medical University. All rights reserved.

10.
Cancer Research ; 82(4 SUPPL), 2022.
Article in English | EMBASE | ID: covidwho-1779491

ABSTRACT

Background: Coronavirus disease 2019 (COVID-19) resulted in a global pandemic, which led to deferral of surgeries for early stage breast cancer during March-June 2020. Institutional guidelines were developed to use neoadjuvant endocrine therapy (NET) as a bridge to surgery. As a follow up to initial data presented at SABCS 2020 demonstrating patient acceptance of NET, the present study provides results from a survey which explored psychosocial factors associated with medication compliance. Objective: Primary objective was to identify any barriers to compliance with NET. Method: This was a single institution, prospective study that surveyed patients diagnosed with DCIS and early stage breast cancer at Perlmutter Cancer Center at NYU Langone Hospital and NYU Langone Hospital-Long Island from March 15, 2020-June 1, 2020. Questions were based on the Beliefs about Medicines Questionnaire specific for endocrine therapy (BMQ-AET) and the Medication Adherence Report Scale. Responses were recorded on a Likert scale and included 7 questions regarding perceptions about breast cancer treatment, 10 questions addressing experience with NET, and 5 questions gauging at adherence to NET. Inclusion criteria were males and females older than 18 years old, with an initial diagnosis of DCIS or early stage HR+ Her2/neu-breast cancer, who were prescribed NET. Descriptive statistics were calculated and subgroups were compared using Fisher's exact tests. Analyses were performed using SAS version 9.4. Results: From March 15-June 1, 2020, 13 patients were diagnosed with DCIS and 29 patients with HR+ Her2/neu-breast cancer for whom NET was recommended. Demographics are shown in Table 1. All 42 patients were female with an average age of 60.9 years. Majority of patients were post-menopause (74%) and predominantly white (64%), with an income of less than $60, 000 (52.4%). Average NET duration was 6.7 weeks. Survey responses displayed in Table 2 indicate statistically significant p values in bold. Patients >50 years old, post-menopause and invasive breast cancer had a stronger belief that NET would be helpful, resulting in greater perception to breast cancer treatment and higher adherence to NET. Patients treated with NET for greater than 4 weeks also felt that NET would make them feel well compared to ≤4 weeks. Interestingly, no significant differences in responses based on education or income level were observed. Conclusion: COVID-19 pandemic presented a unique opportunity to use NET, which is often underutilized outside of clinical trials. In this single institution prospective study, we found that post-menopause patients greater than 50 years old with invasive breast cancer perceived hormonal therapy as beneficial to their health, resulting in increased medication compliance. These findings can be used when counseling patients currently treated with NET as well as those patients may be appropriate for NET in the post-COVID era.

11.
Cancer Research ; 82(4 SUPPL), 2022.
Article in English | EMBASE | ID: covidwho-1779459

ABSTRACT

Background: Neoadjuvant endocrine therapy (NET) has long been limited to patients who were deemed medically unfit for immediate surgery or on clinical trials. Coronavirus disease 2019 (COVID-19) resulted in a global pandemic, which led to deferral of elective surgeries including breast surgeries for early stage breast cancer patients during March-June 2020. Institutional guidelines were developed based on societal recommendations, including NCCN, to use NET as a bridge to surgery. Objective: Primary objective was to establish a database of early stage HR+ Her2/neu-breast cancer patients diagnosed during COVID-19 who were treated with NET as a bridge to surgery. Secondary endpoints include correlation between duration of NET and changes in pathological variables. Method: This was a single institution, retrospective observational study from Perlmutter Cancer Center at NYU Langone Hospital and NYU Langone Hospital-Long Island of DCIS and early stage breast cancer patients diagnosed from March 15, 2020-June 1, 2020 during COVID-19 pandemic. Inclusion criteria were males and females older than 18 years of age and initial diagnosis of DCIS or early stage HR+ Her2/neu-breast cancer who did not require neoadjuvant chemotherapy by established guidelines. Descriptive statistics were calculated separately by DCIS and invasive breast cancer using SAS version 9.4. Results: From March 15-S June 1, 2020, 13 patients who were diagnosed with DCIS and 41 patients with early stage HR+ Her2/neu-invasive breast cancer received NET (Table 1). Of the 41 patients with invasive breast cancer, 19 (46%) had Oncotype DX assay on biopsy specimens;12/19 (63%) had scores 10-14 and 7/19 (37%) had scores 15-25. 38/41 (92.7%) had post-surgery Ki-67% and 16/38 (42.1%) demonstrated maturation arrest (Ki-67 <2.7%). 26/41 (63%) invasive breast cancer patients had pre and post Ki-67% checked while on aromatase inhibitors (AI);21/26 (81%) had a decrease in Ki-67%, 2/26 (7.7%) patients had no change, and 3/26 (11.5%) had an increase. Of those 21 patients, the percent change of Ki-67% from baseline was mean 69.15% ± 22.58 and median 71.83%. No significant associations with changes (pre to post) in Ki-67%, T stage, ER% and PR% in NET for ≤4 weeks and >4 weeks (Table 2). Median duration of NET in invasive breast cancer was 6.85 weeks. 1 patient had a complete pathological response after NET and 2 patients were upstaged from DCIS to invasive carcinoma at the time of surgery. Conclusion: While the sample sizes are small, this is a unique cohort of early stage surgically resectable breast cancer patients who were treated with NET during the COVID-19 pandemic. This real-world data confirms pathological changes, especially decrease in Ki-67% even with short duration use of NET that has been reported in trials of neoadjuvant AI. Long term follow-up for survival outcome is planned.

12.
European Journal of International Law ; 32(4):1191-1220, 2021.
Article in English | Web of Science | ID: covidwho-1769243

ABSTRACT

Personal data protection in investment arbitration is increasingly important as more and more countries enact mandatory personal data protection laws and the COVID-19 pandemic makes online hearings the new normal. Tribunals have to consider critical, yet unresolved, normative questions, such as (i) how data protection laws would influence the trend towards transparency in investment arbitrations brought pursuant to modern investment treaties;(ii) whether a party can invoke a data protection law to reject access to fundamental documents and completely shift the power in an arbitration proceeding;(iii) whether it is good to have multiple data protection laws directly applicable in an investment arbitration;and (iv) whether the so-called Brussels Effect may take hold of investment arbitration. These questions directly address the alleged legitimacy crisis of investment arbitration (for example, procedural transparency and efficiency) in the digital era. They also have a critical impact on the fairness of proceedings and are closely related to the protection of fundamental human rights and the concern of digital surveillance. This article comprehensively maps the consensual and mandatory applications of data protection laws in investment arbitration. Adopting comparative-law and conflict-of-laws methodologies, it intends to provide tentative solutions to the four questions mentioned above.

13.
Leukemia and Lymphoma ; 62(SUPPL 1):S117-S118, 2021.
Article in English | EMBASE | ID: covidwho-1747039

ABSTRACT

Introduction: Bruton tyrosine kinase inhibitor (BTKi) therapy is remarkably effective in a number of B-cell malignancies;however, its continuous use is limited by adverse events (AE) leading to discontinuation. Zanubrutinib is a potent and selective BTKi with the potential to be a safe and effective therapy after intolerance to previous BTKi therapy. Here, we report preliminary results of a phase 2 study of zanubrutinib in patients with B-cell malignancies intolerant to ibrutinib and/or acalabrutinib based on a median follow-up of 6 months. Methods: Patients meeting protocol criteria for intolerance to ibrutinib, acalabrutinib, or both (without documented progressive disease on ibrutinib or acalabrutinib) were given zanubrutinib monotherapy (160mg twice daily or 320mg once daily at investigator's discretion). Recurrence of adverse events that led to intolerance to prior BTKi and additional safety measures were assessed based on the Common Terminology Criteria for AEs v5.0. Investigators determined responses using disease status at study entry as baseline and standard established disease response criteria. Results: As of 1 March 2021 (cutoff), 64 patients (n=48 chronic lymphocytic leukemia/small lymphocytic lymphoma, n=10 Waldenström macroglobulinemia, n=3 mantle cell lymphoma, n=3 marginal zone lymphoma) were enrolled, received ≥1 dose of zanubrutinib, and were analyzed for safety. The median age was 71 y (range, 49-91);the median duration of treatment was 5.9 months (range, 0.6-16.6). The median number of prior regimens was 2 (range, 1-12). Regarding prior BTKi, 55 patients had received ibrutinib monotherapy, eight had received ibrutinib combination therapy, and seven had received acalabrutinib monotherapy. The median number of ibrutinib- or acalabrutinib-intolerant adverse events per patient was 2 (range, 1-5). Most ibrutinib- (75%) and acalabrutinib-intolerant events (75%) did not recur with zanubrutinib (Table 1). A majority (90%) of the recurrent ibrutinib-intolerant events were less severe with zanubrutinib than with ibrutinib. Ibrutinib intolerance events present in >1 patient that did not recur on zanubrutinib were alanine aminotransferase increased, aspartate transaminase increased, neutropenia, and pain in extremity. The ibrutinib-intolerant events that recurred were diarrhea, dizziness, insomnia, nausea, constipation, myalgia, stomatitis, arthralgia, headache, muscle spasm, rash, atrial fibrillation, fatigue, hemorrhage, and hypertension. One-third of the recurrent acalabrutinibintolerant events were less severe with zanubrutinib than with acalabrutinib. The acalabrutinib-intolerant events that recurred were myalgia and arthralgia. Two events of arthralgia that induced acalabrutinib intolerance did not recur with zanubrutinib. No ibrutinib- or acalabrutinib-intolerant events recurred at a higher severity while patients were on zanubrutinib. At cutoff, 57 patients remained on treatment;one withdrew consent due to zanubrutinib-unrelated grade 3 syncope. Grade ≥3 adverse events were reported in 14 patients (21.9%), serious adverse events in five patients (7.8%;pain in jaw;COVID-19 pneumonia;anemia;febrile neutropenia and salmonella infection [occurred in the same patient]), adverse events requiring dose interruptions in 15 patients (23.4%), and adverse events leading to dose reduction in three patients (4.7%). Adverse events led to zanubrutinib discontinuation for three patients (4.7%). One death was reported (COVID-19 pneumonia). Among efficacy evaluable patients (n=48), the disease control rate was 89.6% and the overall response rate was 50.0%. Conclusions: In patients with B-cell malignancies intolerant to ibrutinib and/or acalabrutinib, zanubrutinib therapy was effective and controlled patient's disease or induced responses to therapy, and was well-tolerated;most adverse events that led to discontinuation of previous BTKi therapy did not recur while patients were on zanubrutinib.

14.
Forest Chemicals Review ; 2021(September-October):938-956, 2021.
Article in English | Scopus | ID: covidwho-1728227

ABSTRACT

Objective: This paper aims to investigate the online teaching to college students during the COVID-19 epidemic, and to explore the influence of teachers' online teaching strategies on the learning experience and learning effect of college students, as well as the combined effect of these strategies. Research methods: SPSS and AMOS were adopted to analyze and build structural equation model, the path relationship of curriculum design strategy, explorative strategy and interactive strategy in learning experience and learning effect was discussed. Research findings: It is found that three kinds of online teaching strategies, namely curriculum design strategy, explorative strategy and interactive strategy, have significant influence on the learning experience and learning effect of college students, however, there is no significant causal relationship between learning experience and learning effect. In the interaction of teaching strategies, the combination of Curriculum design strategy and explorative strategy exerts a positive significant impact on the learning effect. Curriculum design strategy and interactive strategy, has a negative significant impact on the learning experience. The combination of curriculum design strategy, explorative strategy and interactive strategy exerts a positive significant impact on learning experience. Value: The combination of teaching strategies should be carefully and appropriately selected in the design of teaching strategies. Only by directly using one of the three teaching strategies can a positive online learning experience and learning effect be achieved. The grade characteristics of students and the choice of learning platforms have no moderating effect on online learning experience and learning effect, while only gender has a moderating effect. © 2021 Kriedt Enterprises Ltd. All Rights Reserved.

15.
2021 IEEE International Conference on Bioinformatics and Biomedicine, BIBM 2021 ; : 556-561, 2021.
Article in English | Scopus | ID: covidwho-1722878

ABSTRACT

Clinical omics, especially gene expression data, have been widely studied and successfully applied for disease diagnosis using machine learning techniques. As genes often work interactively rather than individually, investigating co-functional gene modules can improve our understanding of disease mechanisms and facilitate disease state prediction. To this end, we in this paper propose a novel Multi-Level Enhanced Graph ATtention (MLE-GAT) network to explore the gene modules and intergene relational information contained in the omics data. In specific, we first format the omics data of each patient into co-expression graphs using weighted correlation network analysis (WGCNA) and then feed them to a well-designed multi-level graph feature fully fusion (MGFFF) module for disease diagnosis. For model interpretation, we develop a novel full-gradient graph saliency (FGS) mechanism to identify the disease-relevant genes. Comprehensive experiments show that our proposed MLE-GAT achieves state-of-the-art performance on transcriptomics data from TCGA-LGG/TCGA-GBM and proteomics data from COVID-19/non-COVID-19 patient sera. © 2021 IEEE.

16.
European Respiratory Journal ; 58:2, 2021.
Article in English | Web of Science | ID: covidwho-1704115
17.
20th IEEE Sensors Conference ; 2021.
Article in English | Web of Science | ID: covidwho-1700865

ABSTRACT

In this work, we present the combination of near-infrared spectroscopy and chemometrics to distinguish respiratory syncytial virus (RSV) and Sendai virus (SeV), the first study of its kind. Using a low-cost and portable spectrometer, a total of 440 virus spectra were collected over four separate sessions. The spectra were pre-processed by normalisation and baseline removal, and variable elimination was conducted based on the standard deviation. Partial least squares discrimination analysis was used to model the relationship between the spectra and the virus categories, resulting in the accuracy of 0.825 and 0.855 for validation and prediction, respectively. Since the portable spectrometer has simple operation and can provide analytical results in real time, it can be used as a viable tool for rapid, on-site and low-cost virus screening for RSV, SeV and possibly other similar viruses such as SARS-CoV-2.

18.
Anesthesia and Analgesia ; 132(5S_SUPPL):135-141, 2021.
Article in English | Web of Science | ID: covidwho-1695932
19.
Anesthesia and Analgesia ; 132(5S_SUPPL):318-320, 2021.
Article in English | Web of Science | ID: covidwho-1695931
20.
Acm Transactions on Management Information Systems ; 12(4):24, 2021.
Article in English | Web of Science | ID: covidwho-1691235

ABSTRACT

Modeling infection spread during pandemics is not new, with models using past data to tune simulation parameters for predictions. These help in understanding of the healthcare burden posed by a pandemic and responding accordingly. However, the problem of how college/university campuses should function during a pandemic is new for the following reasons: (i) social contact in colleges are structured and can be engineered for chosen objectives;(ii) the last pandemic to cause such societal disruption was more than 100 years ago, when higher education was not a critical part of society;(iii) not much was known about causes of pandemics, and hence effective ways of safe operations were not known;and (iv) today with distance learning, remote operation of an academic institution is possible. As one of the first to address this problem, our approach is unique in presenting a flexible simulation system, containing a suite of model libraries, one for each major component. The system integrates agent-based modeling and the stochastic network approach, and models the interactions among individual entities (e.g., students, instructors, classrooms, residences) in great detail. For each decision to be made, the system can be used to predict the impact of various choices, and thus enables the administrator to make informed decisions. Although current approaches are good for infection modeling, they lack accuracy in social contact modeling. Our agent-based modeling approach, combinedwith ideas from Network Science, presents a novel approach to contact modeling. A detailed case study of the University of Minnesota's Sunrise Plan is presented. For each decision made, its impact was assessed, and results were used to get a measure of confidence. We believe that this flexible tool can be a valuable asset for various kinds of organizations to assess their infection risks in pandemic-time operations, including middle and high schools, factories, warehouses, and small/medium-sized businesses.

SELECTION OF CITATIONS
SEARCH DETAIL